|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.250
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.244
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.224
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.219
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.166
|
Mouse |
|
|
gland development
|
GO:0048732 |
330 |
0.154
|
Mouse |
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.153
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.142
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.136
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.123
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.118
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.117
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.114
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.106
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.104
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.104
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.101
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.100
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.100
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.097
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.096
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.096
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.095
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.093
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.092
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.092
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.092
|
Mouse |
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.089
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.087
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.087
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.087
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.087
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.085
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.084
|
|
|
|
peptidyl proline hydroxylation
|
GO:0019511 |
3 |
0.084
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.083
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.081
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.081
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.080
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.080
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.077
|
Mouse |
|
|
urogenital system development
|
GO:0001655 |
261 |
0.076
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.074
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.072
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.072
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.072
|
Mouse |
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.070
|
Mouse |
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.070
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.070
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.069
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.069
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.069
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.068
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.065
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.065
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.065
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.063
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.061
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.061
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.061
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.058
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.058
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.057
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.057
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.057
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.057
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.056
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.055
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.055
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.054
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.054
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.054
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.054
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.053
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.053
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.053
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.052
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.052
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.052
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.052
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.051
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.051
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.051
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.050
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.050
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.050
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.050
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.050
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.050
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.050
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.050
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.049
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.049
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.048
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.048
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.048
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.047
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.047
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.047
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.047
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.047
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.047
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.046
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.046
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.046
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.046
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.045
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.045
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.045
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.045
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.044
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.044
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.043
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.043
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.043
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.043
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.043
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.043
|
|
|
|
protein hydroxylation
|
GO:0018126 |
4 |
0.043
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.042
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.042
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.042
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.042
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.041
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.041
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.041
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.041
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.041
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.041
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.040
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.040
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.040
|
Mouse |
|
|
wnt signaling pathway involved in somitogenesis
|
GO:0090244 |
4 |
0.040
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.040
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.039
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.039
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.039
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.039
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.039
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.038
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.038
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.038
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.038
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.037
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.037
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.037
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.037
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.037
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.037
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.037
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.037
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.037
|
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.036
|
|
|
|
negative regulation of planar cell polarity pathway involved in pericardium morphogenesis
|
GO:2000166 |
1 |
0.036
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.036
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.036
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.036
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.036
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.036
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.036
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.036
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.035
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.035
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.034
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.034
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.034
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.034
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.034
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.034
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.034
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.034
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.034
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.033
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.033
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.033
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.033
|
|
|
|
negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:2000149 |
1 |
0.033
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.033
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.033
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.033
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.033
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.032
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.032
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.032
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.032
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.032
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.032
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.032
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.031
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.031
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.031
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.031
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.031
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.031
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.031
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.031
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.031
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.031
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.030
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.030
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.030
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.030
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.030
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.030
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.030
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.030
|
|
|
|
negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:2000162 |
1 |
0.030
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.030
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.030
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.030
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.030
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.030
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.030
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.030
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.029
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.029
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.029
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.029
|
|
|
|
substrate adhesion dependent cell spreading
|
GO:0034446 |
30 |
0.029
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.029
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.029
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.029
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.029
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.029
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.028
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.028
|
Mouse |
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.028
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.028
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.028
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.028
|
|
|
|
regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:2000150 |
1 |
0.028
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.028
|
Mouse |
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.028
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.028
|
Mouse |
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.028
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.028
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.027
|
|
|
|
regulation of planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:2000148 |
1 |
0.027
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.027
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.027
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.027
|
Rat |
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.027
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.027
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.027
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.027
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.027
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.027
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.027
|
Mouse |
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.027
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.026
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.026
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.026
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.026
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.026
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.026
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.026
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.026
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.026
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.026
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.026
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.026
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.026
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.026
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.025
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.025
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.025
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.025
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.025
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.025
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.025
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.025
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.025
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.025
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.025
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.025
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.025
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.024
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.024
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.024
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.024
|
|
|
|
regulation of planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:2000163 |
1 |
0.024
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.024
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.024
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.024
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.024
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.024
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.024
|
|
|
|
beta amyloid clearance
|
GO:0097242 |
2 |
0.024
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.024
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.024
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.023
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.023
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.023
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.023
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.023
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.023
|
|
|
|
negative regulation of neuron projection regeneration
|
GO:0070571 |
3 |
0.023
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.023
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.023
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.023
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.023
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.023
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.023
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.023
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.023
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.023
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.022
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.022
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.022
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.022
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.022
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.022
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.022
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.022
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.022
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.022
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.022
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.022
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.022
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.022
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.022
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.021
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.021
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.021
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.021
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.021
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.021
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.021
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.021
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.021
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.021
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.021
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.021
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.021
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.021
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.020
|
|
|
|
hematopoietic stem cell migration
|
GO:0035701 |
1 |
0.020
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.020
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.020
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.020
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.020
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.020
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.020
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.020
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.020
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.020
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.020
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.020
|
|
|
|
negative regulation of platelet derived growth factor receptor beta signaling pathway
|
GO:2000587 |
2 |
0.020
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.020
|
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.020
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.019
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.019
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.019
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.019
|
Mouse |
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.019
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.019
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.019
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.019
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.019
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.019
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.019
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.019
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.019
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.019
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.019
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.019
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.019
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.019
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.019
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.019
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.019
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.019
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.019
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.019
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.019
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.018
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.018
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.018
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.018
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.018
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.018
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.018
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.018
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.018
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.018
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.018
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.018
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.018
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.018
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.018
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.018
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.018
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.018
|
|
|
|
one carbon metabolic process
|
GO:0006730 |
1 |
0.018
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.018
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.018
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.018
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.018
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.018
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.018
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.018
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.018
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.018
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.018
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.018
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.018
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.018
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.018
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.018
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.018
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.018
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.018
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.017
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.017
|
|
|
|
negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:2000164 |
1 |
0.017
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.017
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.017
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.017
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.017
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.017
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.017
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.017
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.017
|
|
|
|
negative regulation of planar cell polarity pathway involved in heart morphogenesis
|
GO:2000160 |
1 |
0.017
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.017
|
|
|
|
positive regulation of nucleocytoplasmic transport
|
GO:0046824 |
30 |
0.017
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.017
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.017
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.017
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.017
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.017
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.017
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.017
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.017
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.017
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.017
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.017
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.017
|
Mouse |
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.017
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.017
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.017
|
|
|
|
establishment of planar polarity of embryonic epithelium
|
GO:0042249 |
16 |
0.017
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.017
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.016
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.016
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.016
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.016
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.016
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.016
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.016
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.016
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.016
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.016
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.016
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.016
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.016
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.016
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.016
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.016
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.016
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.016
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.016
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.016
|
|
|
|
regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:2000161 |
1 |
0.016
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.016
|
|
|
|
forebrain radial glial cell differentiation
|
GO:0021861 |
4 |
0.016
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.016
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.016
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.016
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.016
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.016
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.016
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.016
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.015
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.015
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.015
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.015
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.015
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.015
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.015
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.015
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.015
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.015
|
|
|
|
positive regulation of protein localization to nucleus
|
GO:1900182 |
30 |
0.015
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.015
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.015
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.015
|
|
|
|
nucleotide sugar metabolic process
|
GO:0009225 |
4 |
0.015
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.015
|
|
